Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena I Boshoff

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
ACS Chemical Biology|July 17, 2012
Development of a selective activity-based probe for adenylating enzymes: profiling MbtA Involved in siderophore biosynthesis from Mycobacterium tuberculosisBenjamin P Duckworth, Daniel J Wilson, Kathryn M Nelson, et al.
Journal of Medicinal Chemistry|June 26, 2015
Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosisKathryn M Nelson, Kishore Viswanathan, Surendra Dawadi, et al.
Bioorganic & Medicinal Chemistry|June 7, 2016
2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosisAnna Krajczyk, Joanna Zeidler, Piotr Januszczyk, et al.
Molecular Diversity|September 12, 2019
Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agentsAshutosh Prasad Tiwari, B Sridhar, Helena I Boshoff, et al.
Molecular Systems Design & Engineering|October 3, 2022
Molecular insights into Mmpl3 leads to the development of novel indole-2-carboxamides as antitubercular agentsRajdeep Ray, Sumit Raosaheb Birangal, Fajeelath Fathima, et al.
Bioorganic & Medicinal Chemistry|January 11, 2026
Structure-activity relationship study of a new class of 2-amino-3,4-dihydroquinazolines as antitubercular agentsLena Trifonov, Helena I Boshoff, Jose Santinni O Roma, et al.
Medchemcomm|March 25, 2017
SAR and identification of 2-(quinolin-4-yloxy)acetamides as <i>Mycobacterium tuberculosis</i> cytochrome <i>bc</i><sub>1</sub> inhibitorsNarisa Phummarin, Helena I Boshoff, Patricia S Tsang, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Synthesis and Structure-Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular AgentsVeena D Yadav, Helena I Boshoff, Lena Trifonov, et al.
Future Medicinal Chemistry|December 25, 2024
Developing novel indoles as antitubercular agents and simulated annealing-based analysis of their binding with MmpL3Rajdeep Ray, Stutee Das, Sumit Raosaheb Birangal, et al.
Molecular Microbiology|December 18, 2012
A novel F(420) -dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agentsMeera Gurumurthy, Martin Rao, Tathagata Mukherjee, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
ACS Chemical Biology|July 17, 2012
Development of a selective activity-based probe for adenylating enzymes: profiling MbtA Involved in siderophore biosynthesis from Mycobacterium tuberculosisBenjamin P Duckworth, Daniel J Wilson, Kathryn M Nelson, et al.
Journal of Medicinal Chemistry|June 26, 2015
Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosisKathryn M Nelson, Kishore Viswanathan, Surendra Dawadi, et al.
Bioorganic & Medicinal Chemistry|June 7, 2016
2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosisAnna Krajczyk, Joanna Zeidler, Piotr Januszczyk, et al.
Molecular Diversity|September 12, 2019
Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agentsAshutosh Prasad Tiwari, B Sridhar, Helena I Boshoff, et al.
Molecular Systems Design & Engineering|October 3, 2022
Molecular insights into Mmpl3 leads to the development of novel indole-2-carboxamides as antitubercular agentsRajdeep Ray, Sumit Raosaheb Birangal, Fajeelath Fathima, et al.
Bioorganic & Medicinal Chemistry|January 11, 2026
Structure-activity relationship study of a new class of 2-amino-3,4-dihydroquinazolines as antitubercular agentsLena Trifonov, Helena I Boshoff, Jose Santinni O Roma, et al.
Medchemcomm|March 25, 2017
SAR and identification of 2-(quinolin-4-yloxy)acetamides as <i>Mycobacterium tuberculosis</i> cytochrome <i>bc</i><sub>1</sub> inhibitorsNarisa Phummarin, Helena I Boshoff, Patricia S Tsang, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Synthesis and Structure-Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular AgentsVeena D Yadav, Helena I Boshoff, Lena Trifonov, et al.
Future Medicinal Chemistry|December 25, 2024
Developing novel indoles as antitubercular agents and simulated annealing-based analysis of their binding with MmpL3Rajdeep Ray, Stutee Das, Sumit Raosaheb Birangal, et al.
Molecular Microbiology|December 18, 2012
A novel F(420) -dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agentsMeera Gurumurthy, Martin Rao, Tathagata Mukherjee, et al.
Pageof 10